1. Food and Drug Administration. 1978. Good laboratory practice for nonclinical laboratory studies. 21 CRF Part 58, good laboratory practice regulations; final rule.
2. The selective estrogen receptor modulator raloxifene;Byrd;Teratology,1996
3. Raloxifene;Sato;J Bone Miner Metab,1994
4. Biochemical pharmacology of antiestrogen action;Jordan;Pharmacol Rev,1984
5. The selective estrogen receptor modulator raloxifene;Buelke-Sam;Reprod Toxicol,1998